Insights,
Insights,
[el-text]
ADVI looks forward to the opportunities for our clients with the advent of a Trump Administration and a Republican Congress. With so much attention being focused on the differences in policy over the ACA between the current Administration and a Trump Presidency we wanted to bring our Lifesciences and healthcare services clients an unbiased and informed view of what they may expect on other issues of market and strategic importance such as the future of value-based payment, quality, price transparency, and more. What follows is gleaned from first hand discussion with the Trump Transition and Congressional staff, as well as the Lifesciences lobby.
[/el-text]
[el-text]
[/el-text]